Efficacy of Lapaquistat Acetate Alone and With Ezetimibe in Subjects With Primary Dyslipidemia.
Clinical trial NCT00268697 · COMPLETED
Trial details
- NCT number
- NCT00268697
- Sponsor
- Takeda
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-10-01
- Primary completion
- 2007-01-01
- Enrollment
- 1267
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.